+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A comparative study of saquinavir , and zidovudine vs ZDV and zalcitabine vs SAQ, ZDV, and ddC



A comparative study of saquinavir , and zidovudine vs ZDV and zalcitabine vs SAQ, ZDV, and ddC



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34: 60




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029619833

Download citation: RISBibTeXText


Related references

Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. Aids 13(7): 851-858, 1999

Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229. Journal of Infectious Diseases 179(1): 249-253, 1999

Resistance Mutations to Zidovudine and Saquinavir in Patients Receiving Zidovudine Plus Saquinavir or Zidovudine and Zalcitabine Plus Saquinavir in Aids Clinical Trials Group 229. The Journal of Infectious Diseases 179(1): 249-253, 1999

Saquinavir + zalcitabine vs saquinavir or zalcitabine monotherapy in HIV-infected patients discontinuing or intolerant to zidovudine Results of a randomized, double blind trial. AIDS (London) 10(Suppl. 2): S17, 1996

Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3. Antiviral Therapy 4(1): 35-44, 1999

Extended treatment with saquinavir , zidovudine , and zalcitabine vs SAQ and ZDV vs ddC and ZDV. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 236, 1995

Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy. Antimicrobial Agents and ChemoTherapy 41(11): 2428-2432, 1997

Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy. Antimicrobial Agents and ChemoTherapy 41(11): 2433-2438, 1997

Effects of combination therapy with saquinavir, zidovudine and zalcitabine on quality of life. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS [Author] Eleventh International Conference on AIDS, Vol One One world: One hope : 239, 1996

Antiretroviral drug cost offsets in seven developed countries Saquinavir, zalcitabine, and zidovudine. AIDS (London) 10(Suppl. 2): S15, 1996

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. New England Journal of Medicine 334(16): 1011-1017, 1996

Randomised, multicentre phase III study of saquinavir plus zidovudine plus zalcitabine in previously untreated or minimally pretreated HIV-infected patients. Clinical Drug Investigation 20(5): 295-307, 2000

Extreme suppression of HIV-1 plasma RNA using a combination of zidovudine, didanosine, zalcitabine, epivir, saquinavir, and interferon-alpha in subjects with HIV-1 infection. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS [Author] Eleventh International Conference on AIDS, Vol Two One world: One hope : 78, 1996

Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors. HIV Medicine 5(1): 11-14, 2004

Zalcitabine in combination with zidovudine for treatment of advanced HIV disease A multicenter, open label, non comparative study. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 225, 1995